Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...